Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
AMEX
Protalix BioTherapeutics Inc (PLX)
Protalix BioTherapeutics Inc (PLX) Financials

PLX Protalix BioTherapeutics Inc

1.76

0.02 (1.15%)

20 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-32.719	-110.418	-39.682	-34.314	-11.512	-38.958	-23.062	11.856
Return on Equity (%)	-6411.572	413.459	62.863	29.668	13.4	166.795	179.024	72.502
Return on Invested Capital (%)	-71.049	-289.7	-602.058	76.547	-10.805	451.6	-75.132	44.154
Operating Margin (%)	-201.228	-392.636	-54.825	-18.851	5.005	-52.31	-24.913	17.934
Net Profit Margin (%)	-319.219	-443.176	-77.269	-33.416	-10.371	-71.922	-31.334	12.691
Book Value Per Share	-0.049	-0.142	-0.239	-0.764	-0.241	-0.049	-0.081	0.223
Earnings Per Share	-0.146	-0.386	-0.12	-0.198	-0.058	-0.225	-0.114	0.055
Cash Per Share	0.314	0.232	0.171	0.193	0.163	0.317	0.131	0.157
Working Capital Per Share	0.028	0.181	0.125	-0.084	-0.274	0.232	0.095	0.162
Operating Profit Per Share	0.004	0.018	0.12	0.493	0.476	0.188	0.222	0.291
EBIT Per Share	-0.145	-0.386	-0.12	-0.198	-0.058	-0.225	-0.11	0.057
EBITDA Per Share	-0.145	-0.386	-0.12	-0.198	-0.058	-0.225	-0.11	0.057
Free Cash Flow Per Share	-0.151	-0.39	-0.124	-0.209	-0.064	-0.222	-0.117	0.055

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	124.13M	143.73M	143.73M	14.84M	34.77M	45.56M	53.79M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	53.79M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-23.853	N/A	N/A	N/A	-115.875	N/A	N/A
Net Profit Margin (%)	N/A	-32.655	N/A	N/A	N/A	-122.599	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	128.12M
Price to Earnings Ratio	15.5
Price to Sales Ratio	1.97
Price to Cash Ratio	5.45
Price to Book Ratio	3.84
Dividend Yield	-

Share Statistics

Shares Outstanding	73.63M
Average Volume (1 week)	393.58k
Average Volume (1 Month)	394.59k
52 Week Change	8.64%
52 Week High	1.90
52 Week Low	0.8214

More Ratios Coming Soon!

Protalix BioTherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions